TNGX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 117867 min ago

@ $11.71

Wydano: 13 vas. 2024 @ 22:42

Zwrot: -35.01%

Poprzedni sygnał: vas. 13 - 16:30

Poprzedni sygnał: Kupno

Zwrot: -1.76 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	330 699
Średni wolumen	617 127
Kapitalizacja rynkowa	812.25M
EPS	$0 ( 2024-03-25 )
Następna data zysków	( $-0.310 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.05
ATR14	$0.00800 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Mva Investors, Llc	Sell	75 000	Common Stock
2024-05-02	Mva Investors, Llc	Sell	75 000	Common Stock
2024-05-03	Mva Investors, Llc	Sell	60 000	Common Stock
2024-02-20	Third Rock Ventures Iv, L.p.	Sell	162 500	Common Stock
2024-02-06	Weber Barbara	Sell	4 681	Common Stock

INSIDER POWER
87.11
Last 93 transactions
Buy: 16 052 308 \| Sell: 875 313

Wolumen Korelacja

Długi: -0.01 (neutral)

Krótki: -0.73 (moderate negative)

Signal:(58.905) Neutral

Tango Therapeutics, Inc. Korelacja

10 Najbardziej pozytywne korelacje
GSMG	0.949
CMLS	0.947
AADI	0.942
AKTX	0.938
DSWL	0.934
TTCF	0.93
DRUG	0.929
INTA	0.928
ACRX	0.928
AROW	0.927

10 Najbardziej negatywne korelacje
MORF	-0.946
CNCE	-0.937
TYHT	-0.934
INOD	-0.93
PLYA	-0.923
EPZM	-0.923
BZ	-0.921
LFMD	-0.918
MOTNU	-0.917
ITI	-0.914

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tango Therapeutics, Inc. Korelacja - Waluta/Towar

0.21
( neutral )

0.04
( neutral )

0.00
( neutral )

-0.04
( neutral )

0.07
( neutral )

Tango Therapeutics, Inc. Finanse

Annual	2023
Przychody:	$36.53M
Zysk brutto:	$34.11M (93.39 %)
EPS:	$-1.080

FY	2023
Przychody:	$36.53M
Zysk brutto:	$34.11M (93.39 %)
EPS:	$-1.080

FY	2022
Przychody:	$24.86M
Zysk brutto:	$20.83M (83.80 %)
EPS:	$-1.230

FY	2021
Przychody:	$37.04M
Zysk brutto:	$37.04M (100.00 %)
EPS:	$-3.49

Financial Reports:

No articles found.

Tango Therapeutics, Inc.

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.